SharonXLiangMDPhD

Obstetrics & Perinatal Pathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Associate Professor, Pathology and Laboratory Medicine, Hofstra North Shore-LIJ School of Medicine

Dr. Liang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
320 E North Ave
Pittsburgh, PA 15212
Phone+1 412-359-6886

Fax+1 412-359-3598

Yale-New Haven Medical CenterFellowship, Gynecologic Pathology, 2002 - 2003
UMass Chan Medical SchoolResidency, Pathology-Anatomic and Clinical, 1998 - 2002
Hunan Medical UniversityClass of 1984

PubMed

1473 citations
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk
The New England Journal of Medicine. 2011-12-28
13 citations
Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid ...
Oluwole Fadare, Sharon X. Liang
Annals of Diagnostic Pathology. 2008-12-01
264 citations
Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer
Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro, Barbara M. Norquist, Elizabeth M. Swisher
Journal of Clinical Oncology. 2019-06-19

Burning Rock Reports Second Quarter 2021 Financial ResultsAugust 31st, 2021
Public Workshop - Next Generation Sequencing-Based Oncology Panels, February 25, 2016February 25th, 2016